Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transdermal Drug Delivery Systems01:18

Transdermal Drug Delivery Systems

157
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
157
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

5.2K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
5.2K
Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

67
Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
67
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

2.0K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.0K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

376
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
376
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

354
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
354

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of saturation dynamics in driving skin permeation from topical gel formulations.

Journal of pharmaceutical sciences·2026
Same author

Development and in vivo evaluation of novel bioresponsive nanocubosomal in-situ gelling system for ophthalmic delivery of Amphotericin B.

International journal of pharmaceutics·2026
Same author

Cubosomes as Versatile Multifunctional Lipid-Based Nanocarriers for Drug Delivery: A Comprehensive Review.

Current pharmaceutical design·2026
Same author

Evaluation of Critical Quality Attributes of Topical Foam Formulations.

AAPS PharmSciTech·2026
Same author

A review exploring the translational perspective of artificial intelligence in drug discovery and formulation development.

Annales pharmaceutiques francaises·2026
Same author

Activation-modulated stimuli-responsive systems: an intelligent platform for site-specific gastroretentive delivery of diverse therapeutic agents.

International journal of pharmaceutics·2026

Related Experiment Video

Updated: Apr 7, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.6K

Transdermal iron replenishment therapy.

Naresh Modepalli1, H N Shivakumar2, K L Paranjothy Kanni2

  • 1Department of Pharmaceutics & Drug Delivery, The University of Mississippi, MS 38677, USA.

Therapeutic Delivery
|July 8, 2015
PubMed
Summary

Transdermal iron delivery offers a novel solution for iron deficiency anemia, potentially overcoming side effects of oral and parenteral methods. This approach shows promise for improving patient compliance and treatment outcomes.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

1.0K

Related Experiment Videos

Last Updated: Apr 7, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.6K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

1.0K

Area of Science:

  • Nutritional Science
  • Biomedical Engineering
  • Pharmacology

Background:

  • Iron deficiency anemia is a significant global nutritional disorder.
  • Conventional iron therapies (oral, parenteral) have limitations including side effects and poor patient compliance.
  • Transdermal delivery presents an alternative route for iron supplementation.

Purpose of the Study:

  • To review the importance of iron and the impact of iron deficiency anemia.
  • To explore transdermal approaches for delivering iron.
  • To evaluate the efficacy of transdermal iron delivery systems.

Main Methods:

  • Review of literature on iron's importance and deficiency effects.
  • Investigation of transdermal delivery systems for iron.
  • Selection of ferric pyrophosphate and iron dextran as iron sources.
  • Utilisation of biophysical techniques to assess skin permeation.
  • In vivo studies using anemic rat models.

Main Results:

  • Transdermal iron delivery systems were investigated for efficacy.
  • Ferric pyrophosphate and iron dextran were identified as suitable iron sources.
  • Biophysical and in vivo studies demonstrated potential for transdermal iron transport.
  • The approach aims to mitigate side effects associated with conventional iron therapies.

Conclusions:

  • Transdermal iron delivery is a promising therapeutic strategy.
  • This method has the potential to improve patient compliance and treatment outcomes for iron deficiency anemia.
  • Further development could lead to a significant positive impact on patient health.